SANDEEP K GUPTA

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology BIRMINGHAM, AL NPI 1154436616

General Payments — all program years on this page

$36,068.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,959.90 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $11,868.004
Travel and Lodging $572.053
Food and Beverage $519.8511

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $5,177.735
GENZYME CORPORATION $4,812.904
Acerta Pharma LLC $2,148.001
Abbott Laboratories $821.278

By program year

Program yearAmountRecords
2018 $3,863.339
2019 $200.001
2020 $3,428.037
2021 $1,368.001
2022 $11,143.007
2023 $3,105.786
2024 $12,959.9018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104587516 AstraZeneca Pharmaceuticals LP $2,148.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1124872066 Abbott Laboratories $25.87 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124872068 Abbott Laboratories $26.29 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124872070 Abbott Laboratories $35.32 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124872072 Abbott Laboratories $26.35 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124872074 Abbott Laboratories $135.39 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125391674 Abbott Laboratories $449.18 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125391676 Abbott Laboratories $113.85 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125391678 Abbott Laboratories $9.02 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137565593 Takeda Pharmaceuticals U.S.A., Inc. $2,490.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137565598 Takeda Pharmaceuticals U.S.A., Inc. $124.74 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137565601 Takeda Pharmaceuticals U.S.A., Inc. $44.49 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137565605 Takeda Pharmaceuticals U.S.A., Inc. $2,490.00 05/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137565609 Takeda Pharmaceuticals U.S.A., Inc. $28.50 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139605089 GENZYME CORPORATION $19.94 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139605119 GENZYME CORPORATION $32.64 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139605169 GENZYME CORPORATION $20.32 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139605173 GENZYME CORPORATION $4,740.00 01/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.